Circle November 6 - Huge Tesla News?

Tesla could be about to change forever. On November 6, insiders are warning of a "critical inflection point", which could have a dramatic impact on the stock market. Do not buy OR sell Tesla stock until you have all the facts.

What's Really Inside Huawei's 'Domestic' AI Chips?

Anusuya Lahiri
October 03, 2025

Huawei's latest AI chips, promoted as a milestone in China's push for technological self-reliance, continue to rely on critical components from Taiwan Semiconductor Manufacturing Co. (NYSE:TSM), Samsung (OTC:SSNLF), and SK Hynix, a teardown by TechInsights reveals.

The findings highlight China's continued dependence on foreign hardware, even as Beijing pushes to expand its domestic semiconductor capabilities, Bloomberg reported on Friday.

The report found that Taiwan Semiconductor produced the dies powering Huawei's Ascend 910C processors, while Samsung and SK Hynix supplied older-generation high-bandwidth memory (HBM2E) used in separate chip samples.

Also Read: Taiwan Semiconductor Halts Shipments After Huawei Link Discovered, US Sanctions Cited

Both Korean companies emphasized to Bloomberg that they halted sales to Huawei following U.S. export controls in 2020 and remain compliant with American regulations. Huawei, added to the U.S. Entity List under President Donald Trump, did not comment during China's Golden Week holiday.

U.S. authorities have tightened controls on AI chips, HBM memory, and the equipment required to manufacture them, aiming to limit Beijing's ability to challenge Nvidia (NASDAQ:NVDA) in advanced computing.

Despite these restrictions, Huawei has leveraged its stockpiled inventory. Analysts estimate the company acquired nearly 3 million Taiwan Semiconductor dies through intermediary Sophgo before sanctions severed the channel, and these continue to power the 910C chips, which entered mass shipment earlier this year.

Still, supply risks are mounting. SemiAnalysis projects Huawei could face high-bandwidth memory shortages by the end of 2025 as domestic players like Changxin Memory Technologies (CXMT) race to bridge the gap.

The pressure on Huawei's supply chain intensified after reports in December 2024 suggested the Biden administration was considering blacklisting Sophgo.

Investigators discovered a Taiwan Semiconductor chip inside Huawei's Ascend 910B processor, prompting Taiwan Semiconductor to halt shipments to Sophgo and notify the U.S. Commerce Department.

Washington flagged Sophgo, an affiliate of Bitcoin miner Bitmain and a supplier to Chinese state firms, as a national security concern.

Huawei is pressing ahead with efforts to rival Nvidia in terms of AI performance. At its annual Huawei Connect conference, rotating Chairman Eric Xu unveiled a three-year plan to cluster large numbers of Ascend processors via a new UnifiedBus interconnect system, claiming it can transfer data up to 62 times faster than Nvidia's upcoming NVLink144.

The presentation underscored Beijing's strategy of supporting Huawei as a national champion amid U.S. curbs, even as analysts caution that Huawei's chips still trail Nvidia's in raw processing power and remain at 7-nanometer designs.

Huawei's high-profile chip rollout reflects China's ambition to achieve technological sovereignty, but analysts warn that supply chain vulnerabilities could slow its advance.

Read Next:

  • Huawei Technologies Challenges Nvidia AI Chip Dominance In China

Photo via Shutterstock

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o

Why Are Concorde International Group Shares Soaring 80% After Hours?

Concorde International Group Ltd. saw an 80.16% increase in after-hours trading on Wednesday, reaching $4.63, following the approval of its 2025 Equity Incentive Plan by its Board of Directors and Compensation Committee.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Ex-Trump Lawyer Raises Alarms: 'I Have Never Been As Concerned As To Whether Our System Can Withstand The Pressure'

Abbe Lowell, a lawyer who once represented President Donald Trump's family, has expressed grave concerns over the potential harm the current administration could cause to the country's institutions.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Gold Success Absent From Fund Allocation, Survey Shows

Gold is soaring to its second-best year in half a century, up over 43% as investors hedge against inflation and geopolitical risks.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Why Rivian Automotive Stock Is Gaining Today?

Rivian stock climbs after breaking ground on a multibillion-dollar Georgia EV plant.

Elon Musk Says November 6 Could "Affect the Future of the World" - Ad

Get ready for the biggest pivot in corporate history. Tesla insiders are preparing for a dramatic new product launch - not driverless cars - that could change everything. You're running out of time to prepare.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

Why Redwire Stock Is Gaining Today

Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.

Elon's $1,000,000,000,000 Payday - Ad

Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market. If his plan succeeds, this is the stock to own.

FedEx Bets On Cost Cuts To Boost Margins, Says Analyst

FDX shares surge on strong quarterly performance, exceeding revenue and profit expectations. Bank of America raises price forecast to $244.

Trump Poised To Delay TikTok Deadline Again Amid US–China Tension: 'We May Let It Die'

President Donald Trump is expected to extend the TikTok divestment deadline for a fourth time as ByteDance, valued at $330 billion with surging revenue, faces U.S.–China tensions over its prized algorithm.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Will mortgage rates drop further after the Fed's rate cut? Not necessarily

LOS ANGELES (AP) — Hoping that mortgage rates will keep dropping following since last year? Don't bank on it.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

Lennar Shares Are Trading Lower Friday: What's Going On?

Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Economists Warn 'Stagflation Is In The Room' Amid Interest Rate Cut News: 'The Fed Has No Idea Where Inflation Will Be,' Says Peter Schiff

Leading economists are reacting to the Federal Reserve's decision to cut interest rates by 25 basis points on Wednesday, with some lauding the central bank's independence, and others warning of difficult times ahead.

Circle November 6 - Huge Tesla News? - Ad

Tesla could be about to change forever. On November 6, insiders are warning of a "critical inflection point", which could have a dramatic impact on the stock market. Do not buy OR sell Tesla stock until you have all the facts.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

Nvidia to invest $5 billion in Intel; companies will work together on AI infrastructure and PCs

NEW YORK (AP) — Nvidia, the world's leading chipmaker, announced on Thursday that it's investing $5 billion in Intel and it will collaborate with the struggling semiconductor company on products.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

What a possible Fed rate cut would mean for your finances

NEW YORK (AP) — The Federal Reserve is expected to cut its benchmark interest rate Wednesday for the first time in nine months. Since the last cut, while the . That means Americans are dealing with both high prices and a challenging job market.

Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion

Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Bitcoin Gets The Jitters Around $115,000: Up Or Down Ahead Of FOMC Day?

Bitcoin's (CRYPTO: BTC) tapped $116,000 before retracing below $115,000 on Monday, signaling that fresh catalysts may be needed to lift sentiment as weakening metrics signal a potential pullback.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service